These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 33904280

  • 1. [Evaluation of the preliminary clinical effect of flap-raising combined with cortical-perforation technique in tooth extraction cases of patients with potential risk of medication-related osteonecrosis of the jaw].
    Guo YX, Wang DC, Liu XJ, Wang EB, An JG, Peng X, Guo CB.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 May 09; 56(5):452-457. PubMed ID: 33904280
    [Abstract] [Full Text] [Related]

  • 2. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A, Sasaki M, Schmelzeisen R, Oyama Y, Mori Y, Voss PJ.
    Clin Oral Investig; 2017 Jan 09; 21(1):127-134. PubMed ID: 26924135
    [Abstract] [Full Text] [Related]

  • 3. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G, Manfredi M, Giovannacci I, Mergoni G, Sarraj A, Mureddu M, Giunta G, Bonanini M, Meleti M, Vescovi P.
    Minerva Stomatol; 2017 Aug 09; 66(4):135-140. PubMed ID: 28497661
    [Abstract] [Full Text] [Related]

  • 4. Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.
    Hasegawa T, Hayashida S, Kondo E, Takeda Y, Miyamoto H, Kawaoka Y, Ueda N, Iwata E, Nakahara H, Kobayashi M, Soutome S, Yamada SI, Tojyo I, Kojima Y, Umeda M, Fujita S, Kurita H, Shibuya Y, Kirita T, Komori T, Japanese Study Group of Co-operative Dentistry with Medicine (JCDM).
    Osteoporos Int; 2019 Jan 09; 30(1):231-239. PubMed ID: 30406309
    [Abstract] [Full Text] [Related]

  • 5. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
    Moreno-Rabié C, Fontenele RC, Oliveira-Santos N, Nogueira-Reis F, Van den Wyngaert T, Jacobs R.
    Osteoporos Int; 2024 Aug 09; 35(8):1431-1440. PubMed ID: 38767743
    [Abstract] [Full Text] [Related]

  • 6. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S, Tröltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C.
    J Craniomaxillofac Surg; 2015 Jul 09; 43(6):847-54. PubMed ID: 25958767
    [Abstract] [Full Text] [Related]

  • 7. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S, Hayashida S, Funahara M, Sakamoto Y, Kojima Y, Yanamoto S, Umeda M.
    PLoS One; 2018 Jul 09; 13(7):e0201343. PubMed ID: 30048523
    [Abstract] [Full Text] [Related]

  • 8. [Preliminary study on the etiological characteristics and clinical treatment of medication-related osteonecrosis of the jaws].
    Hou W, Dong XT, Wu TT, Ma XF, Zhang XH, Hou CL, Liu XH.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Jul 09; 56(7):659-664. PubMed ID: 34275221
    [Abstract] [Full Text] [Related]

  • 9. [Application of double-layer soft tissue suture closure technique in the surgical treatment of patients with mandible medication-related osteonecrosis of the jaw of early and medium stages].
    Zhou Y, Zhao N, Huang H, Li Q, Guo C, Guo Y.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb 18; 56(1):51-56. PubMed ID: 38318896
    [Abstract] [Full Text] [Related]

  • 10. Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study.
    Cuozzo A, Iorio-Siciliano V, Vaia E, Mauriello L, Blasi A, Ramaglia L.
    J Stomatol Oral Maxillofac Surg; 2022 Nov 18; 123(6):616-621. PubMed ID: 35609780
    [Abstract] [Full Text] [Related]

  • 11. Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction.
    Moreno-Rabié C, Gaêta-Araujo H, Ferreira-Leite A, Coucke W, Gielen E, Van den Wyngaert T, Jacobs R.
    Oral Dis; 2024 Apr 18; 30(3):1632-1642. PubMed ID: 36620873
    [Abstract] [Full Text] [Related]

  • 12. [Clinical analysis of 24 cases of bisphosphonate-related osteonecrosis of the jaw].
    Guo Y, Wang D, An J, Peng X, Cai Z, Guo C.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Sep 18; 49(9):517-20. PubMed ID: 25476210
    [Abstract] [Full Text] [Related]

  • 13. Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.
    Zheng Y, Dong X, Chen S, He Y, An J, Liu M, He L, Zhang Y.
    BMC Oral Health; 2023 Jan 10; 23(1):14. PubMed ID: 36627695
    [Abstract] [Full Text] [Related]

  • 14. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?
    Ueda N, Nakashima C, Aoki K, Shimotsuji H, Nakaue K, Yoshioka H, Kurokawa S, Imai Y, Kirita T.
    Clin Oral Investig; 2021 May 10; 25(5):3087-3093. PubMed ID: 33057886
    [Abstract] [Full Text] [Related]

  • 15. Survey of the association between tooth extraction and development of medication-related osteonecrosis of the jaw in patients undergoing cancer treatment with bone-modifying agents.
    Nozawa-Kobayashi M, Sakuma H, Kanemaru H, Kurokawa A, Soga M, Yamashita M, Niimi K, Kobayashi T.
    Oral Maxillofac Surg; 2024 Jun 10; 28(2):849-857. PubMed ID: 38296902
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of bone perfusion through cortical perforations to improve healing of medication-related osteonecrosis of the jaw: a retrospective study.
    Guo Y, Guo C.
    Int J Oral Maxillofac Surg; 2021 Jun 10; 50(6):740-745. PubMed ID: 33023802
    [Abstract] [Full Text] [Related]

  • 17. Pulpal Disease Arising from Medication-related Osteonecrosis of the Jaw: A Case Report.
    Kiho K, Sumitomo S, Tanaka M, Hasegawa T, Sakai C, Takitani Y, Yoshida T, Kawano S.
    J Endod; 2020 Aug 10; 46(8):1149-1154. PubMed ID: 32437788
    [Abstract] [Full Text] [Related]

  • 18. Surgical treatment of severe medication-related osteonecrosis of the jaw.
    Feng Z, An J, Zhang Y, He Y.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Feb 01; 41(1):43-51. PubMed ID: 38596940
    [Abstract] [Full Text] [Related]

  • 19. The observational study of delayed wound healing after tooth extraction in patients receiving oral bisphosphonate therapy.
    Hasegawa T, Ri S, Umeda M, Komatsubara H, Kobayashi M, Shigeta T, Yoshitomi I, Ikeda H, Shibuya Y, Asahina I, Komori T.
    J Craniomaxillofac Surg; 2013 Oct 01; 41(7):558-63. PubMed ID: 23332469
    [Abstract] [Full Text] [Related]

  • 20. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts.
    Zhao N, Li QX, Wang YF, Qiao Q, Huang HY, Guo CB, Guo YX.
    BMC Oral Health; 2023 May 27; 23(1):330. PubMed ID: 37245004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.